These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of experimental hyperoxaluria on renal calcium oxalate monohydrate binding proteins in the rat. Kalaiselvi P; Selvam R BJU Int; 2001 Jan; 87(1):110-6. PubMed ID: 11122003 [TBL] [Abstract][Full Text] [Related]
3. Studies on calcium oxalate binding proteins: effect of lipid peroxidation. Selvam R; Kalaiselvi P Nephron; 2001 Jun; 88(2):163-7. PubMed ID: 11399920 [TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress. Asokan D; Kalaiselvi P; Varalakshmi P Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748 [TBL] [Abstract][Full Text] [Related]
5. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Selvam R Urol Res; 2002 Mar; 30(1):35-47. PubMed ID: 11942324 [TBL] [Abstract][Full Text] [Related]
6. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein. Srinivasan S; Kalaiselvi P; Varalakshmi P Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257 [TBL] [Abstract][Full Text] [Related]
7. Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells. Govindaraj A; Selvam R Urol Res; 2001 Jun; 29(3):194-8. PubMed ID: 11482446 [TBL] [Abstract][Full Text] [Related]
8. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix. Govindaraj A; Selvam R BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075 [TBL] [Abstract][Full Text] [Related]
9. A novel basic protein from human kidney which inhibits calcium oxalate crystal growth. Selvam R; Kalaiselvi P BJU Int; 2000 Jul; 86(1):7-13. PubMed ID: 10886075 [TBL] [Abstract][Full Text] [Related]
10. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro]. Atmani F; Lacour B; Daudon M Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564 [TBL] [Abstract][Full Text] [Related]
11. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440 [TBL] [Abstract][Full Text] [Related]
12. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis. Aggarwal S; Tandon C; Forouzandeh M; Singla SK; Kiran R; Jethi RK Indian J Biochem Biophys; 2005 Apr; 42(2):113-7. PubMed ID: 23923571 [TBL] [Abstract][Full Text] [Related]
13. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Khan SR; Thamilselvan S Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696 [TBL] [Abstract][Full Text] [Related]
14. Effect of gamma-glutamyl carboxylation of renal microsomes on calcium oxalate monohydrate crystal binding in hyperoxaluria. Angayarkanni N; Selvam R Nephron; 1999; 81(3):342-6. PubMed ID: 10050091 [TBL] [Abstract][Full Text] [Related]
15. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Coe FL; Nakagawa Y; Asplin J; Parks JH Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700 [TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporin A treatment on renal calcium oxalate binding in experimental hyperoxaluria. Adhirai M; Sakthivel R; Selvam R Mol Cell Biochem; 2002 Jul; 236(1-2):1-5. PubMed ID: 12190107 [TBL] [Abstract][Full Text] [Related]